TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients

BACKGROUND: Angiogenesis appears to play an important role in ovarian cancer. Vascular endothelial growth factor (VEGF) has recently been implicated as a therapeutic target in ovarian cancer. The tissue inhibitor of metalloproteinase 1 (TIMP-1) is involved in tissue invasion and angiogenesis. The ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahner, Sven, Woelber, Linn, Eulenburg, Christine, Schwarz, Joerg, Carney, Walter, Jaenicke, Fritz, Milde-Langosch, Karin, Mueller, Volkmar
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873384/
https://www.ncbi.nlm.nih.gov/pubmed/20388222
http://dx.doi.org/10.1186/1471-2407-10-139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873384/
https://www.ncbi.nlm.nih.gov/pubmed/20388222
http://dx.doi.org/10.1186/1471-2407-10-139

Ejemplares similares